ETORICOXIB

Etoricoxib is a selective COX‑2 inhibitor reducing pain and inflammation while sparing gastric COX‑1. Side effects include edema, hypertension, and increased cardiovascular risk.

SKU: 2a033e49ff7a Category: Tag:

Product Description


Mechanism of Action

Etoricoxib is a selective COX‑2 inhibitor that reduces prostaglandin synthesis involved in inflammation, pain transmission and fever. Its high COX‑2/COX‑1 selectivity aims to minimize GI toxicity associated with nonselective NSAIDs.

Benefits and Advantages

Used in COX‑2 selectivity assays, inflammation‑biology research, prostaglandin‑pathway modelling, and selective‑NSAID comparative studies.

Side Effects and Risks

Risks include increased cardiovascular risk, hypertension, edema and rare GI complications. Handle with selective‑COX‑2 inhibitor precautions.

Datasheet


Molecular Formula

C18H15ClN2O2S

Molecular Weight

358.8 g/mol

CAS Number

202409-33-4

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

3.28e-03 g/L

Purity

Purity information is available upon request (COA).

Synonym

Etoricoxib; 202409-33-4; Arcoxia; MK-0663; 5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine

IUPAC/Chemical Name

5-chloro-2-(6-methyl-3-pyridinyl)-3-(4-methylsulfonylphenyl)pyridine

InChl Key

MNJVRJDLRVPLFE-UHFFFAOYSA-N

InChl Code

InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/123619;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download